Our Products

Eisai Inc. is a human health care (hhc) company that seeks to discover and develop innovative therapies that can help satisfy unmet medical needs and contribute to the health and well being of people worldwide. Our hhc mission means that we regard patients and their families as the most important participants in the health care process and we are dedicated to helping improve their lives.

As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., our key areas of commercial focus are neurology, oncology and metabolic diseases. In addition to our marketed products, Eisai invests in a diverse R&D pipeline in an effort to bring new treatments to patients in need.

Injection for Intravenous Use
Tablets
Tablets and Oral Suspension
Tablets
Tablets and Oral Suspension. Please see the FYCOMPA full prescribing information for Boxed Warning and additional Important Safety Information.
Injection
Gel 0.1%
Authorized Distributors of Record
Information for our wholesale and retail customers in the United States.